A Dual-Route Perspective of SARS-CoV-2 Infection: Lung- vs. Gut-specific Effects of ACE-2 Deficiency
Pharmacology
[키워드] ACE-2
ACE-2 receptor
addition
angiotensin-converting enzyme 2
binding
blood pressure
clinical trial
Comorbidity
component
contribute
COVID-19
COVID-19 pathology
Critical
deficiency
diabete
disease
dysregulation
Effect
Effects
Endocrine
Evidence
expressed
function
functions
Gastrointestinal infection
gastrointestinal problem
GI Tract
Gut
hypertension
increasingly
inhibitor
involved
Kidney disease
Local
lung
microbiota
Mortality
Multiorgan
obesity
organ-specific
RAAS
RAAS inhibitors
receptor
Regulation
respiratory tract
respiratory virus
SARS-CoV-2
severity
Therapeutic approach
tissue
while
[DOI] 10.3389/fphar.2021.684610 PMC 바로가기 [Article Type] Pharmacology
[DOI] 10.3389/fphar.2021.684610 PMC 바로가기 [Article Type] Pharmacology